ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $440.41 million. The enterprise value is $40.04 million.

Market Cap	440.41M
Enterprise Value	40.04M

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 291.66 million shares outstanding. The number of shares has increased by 32.24% in one year.

Current Share Class	127.97M
Shares Outstanding	291.66M
Shares Change (YoY)	+32.24%
Shares Change (QoQ)	+66.22%
Owned by Insiders (%)	20.96%
Owned by Institutions (%)	35.82%
Float	70.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.09, with a Debt / Equity ratio of 0.01.

Current Ratio	17.09
Quick Ratio	16.36
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15,099.10

Financial Efficiency

Return on equity (ROE) is -31.34% and return on invested capital (ROIC) is -21.43%.

Return on Equity (ROE)	-31.34%
Return on Assets (ROA)	-20.37%
Return on Capital (ROIC)	-21.43%
Revenue Per Employee	n/a
Profits Per Employee	-$279,810
Employee Count	163
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ProKidney has paid $491,000 in taxes.

Income Tax	491,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.03% in the last 52 weeks. The beta is 1.41, so ProKidney's price volatility has been higher than the market average.

Beta (5Y)	1.41
52-Week Price Change	-17.03%
50-Day Moving Average	1.83
200-Day Moving Average	2.21
Relative Strength Index (RSI)	37.89
Average Volume (20 Days)	500,512

Short Selling Information

The latest short interest is 10.62 million, so 3.64% of the outstanding shares have been sold short.

Short Interest	10.62M
Short Previous Month	10.70M
Short % of Shares Out	3.64%
Short % of Float	15.09%
Short Ratio (days to cover)	22.85

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-150.99M
Pretax Income	-34.94M
Net Income	-45.61M
EBITDA	-145.99M
EBIT	-150.99M
Earnings Per Share (EPS)	-$0.56

Full Income Statement

Balance Sheet

The company has $406.81 million in cash and $6.44 million in debt, giving a net cash position of $400.37 million or $1.37 per share.

Cash & Cash Equivalents	406.81M
Total Debt	6.44M
Net Cash	400.37M
Net Cash Per Share	$1.37
Equity (Book Value)	443.47M
Book Value Per Share	-7.66
Working Capital	405.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$127.56 million and capital expenditures -$5.57 million, giving a free cash flow of -$133.14 million.

Operating Cash Flow	-127.56M
Capital Expenditures	-5.57M
Free Cash Flow	-133.14M
FCF Per Share	-$0.46

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.24%
Shareholder Yield	-32.24%
Earnings Yield	-10.36%
FCF Yield	-30.23%

Dividend Details

Analyst Forecast

The average price target for ProKidney is $4.50, which is 198.01% higher than the current price. The consensus rating is "Buy".

Price Target	$4.50
Price Target Difference	198.01%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-14.51%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a